MRI as a second-line screening tool

02 Oct 2013

After having completed 250 cases where MRI's were performed before biopsies on patients with raised PSA, the study concluded that if the MRI is negative, it is highly accurate. This suggests that perhaps one can avoid biopsies in this situation. Furthermore if the MRI is positive, it also improves the accuracy of targeting the tumour. This study will change the way patients are assessed for prostate cancer. A recent review performed for general practitioners in Australia appeared in Medicine Today.

About Phillip

Phillip is the Chairman of the Department of Urology, St Vincent's Private Hospital and Clinic since 2003, and a Director of the St Vincent's Prostate Cancer Centre.

The Australian Prostate Cancer Research Centre in New South Wales recently appointed him as clinical director. He is also a member of the National Prostate Cancer Research Centre

Philip is currently the highest volume robotic surgeon in Australasia

He is perhaps best known for his work developing nerve sparing techniques to help patients maximise potency